Genetic Changes in HIV-1 Gag-Protease Associated with Protease Inhibitor-Based Therapy Failure in Pediatric Patients

Similar Items

• Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based Therapy
  od: Giandhari, Jennifer, i dr.
  Izdano: (2016)
• Rapid Development of Antiretroviral Drug Resistance Mutations in HIV-Infected Children Less Than Two Years of Age Initiating Protease Inhibitor-Based Therapy in South Africa
  od: Taylor, Barbara S., i dr.
  Izdano: (2011)
• Concordance between allele-specific PCR and ultra-deep pyrosequencing for the detection of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations
  od: Hunt, Gillian M, i dr.
  Izdano: (2014)
• Adherence and Viral Suppression among Infants and Young Children Initiating Protease Inhibitor-Based Antiretroviral Therapy
  od: Teasdale, Chloe A, i dr.
  Izdano: (2013)
• Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial
  od: Kuhn, Louise, i dr.
  Izdano: (2012)